Laboratoires Perouse v. W.L. Gore & Associates, Inc.

528 F. Supp. 2d 362, 2007 U.S. Dist. LEXIS 90848, 2007 WL 4323000
CourtDistrict Court, S.D. New York
DecidedDecember 10, 2007
Docket06 Civ. 5276(RJH)
StatusPublished
Cited by2 cases

This text of 528 F. Supp. 2d 362 (Laboratoires Perouse v. W.L. Gore & Associates, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Laboratoires Perouse v. W.L. Gore & Associates, Inc., 528 F. Supp. 2d 362, 2007 U.S. Dist. LEXIS 90848, 2007 WL 4323000 (S.D.N.Y. 2007).

Opinion

*367 MEMORANDUM OPINION AND ORDER

RICHARD J. HOLWELL, District Judge.

BACKGROUND

I. Procedural History

This is an action for patent infringement brought by Plaintiff Laboratoires Perouse, S.A.S. (“Perouse”) against Defendant Plaintiff W.L. Gore & Associates, Inc. (“Gore”). Perouse alleges that Gore has infringed U.S. Patent No. 6,019,787 (“the '787 patent”) by making, using, selling, and/or offering for sale in the United States products including Gore’s TAG® thoracic endoprosthesis devices and EX-CLUDER® bifurcated endoprosthesis devices. (Compl.1ffl 9-10.) Gore has filed a counterclaim for a declaratory judgment that (1) the '787 patent is invalid under the patent laws, and (2) that Gore has not infringed any claim of the '787 patent. (Answer ¶¶ 22-45.)

The parties identified claim language requiring construction, completed simultaneous briefing on claim construction, and submitted their opening and reply briefs to the Court on August 15, 2007. On September 21, 2007, Perouse filed a “Motion to Exclude Defendant/Counterclaim Plaintiffs Newly Proposed Claim Constructions” (“Motion to Exclude”), in which Per-ouse requested that this Court exclude and refuse to consider claim constructions allegedly presented for the first time in connection with Gore’s reply brief on claim construction. (Perouse Mot. to Exclude Br. 1.) On October 23 and 29, 2007, the Court held Markman hearings at which the parties argued their proposed constructions of the disputed claim terms in the '787 patent.

II. The'787 Patent 1

The '787 patent is entitled “Fitting tool for use of an expansible endoprosthesis for a human or animal tubular organ.” The specification of the '787 patent describes a self-expanding stent 2 (also known as an “auto-expansible endoprosthesis”) and a tool for implanting a self-expanding stent in a desired location within a blood vessel in the body. The claims of the '787 patent cover only the “tool” invention. Claim 1, the only independent claim in the '787 patent, recites “[a] tool for fitting a self-expanding stent.” The tool of claim 1 includes three elements: (1) a “guide tube,” which allows the tool to follow a guide wire through a blood vessel to an appropriate location in the body; (2) a “housing part,” which is located at the distal end of the guide tube and houses the self-expanding stent prior to deployment at the treatment site; and (3) a “housing part opener,” which “opens” the housing part once positioned, allowing the stent to expand radially and hold open the walls of the blood vessel.

The specification of the '787 patent describes two embodiments of the invention. The two embodiments differ only in the “means for opening the ... housing part” used by each. The first embodiment in- *368 eludes a set of wires attached to an actuation handle. When the handle is pulled, the wires cut the housing part (shown in the patent drawings as a cylindrical structure) and allow the self-expanding stent to expand. In the second embodiment, the housing part is slit longitudinally. The opposing edges of the slit are each lined with “gussets,” which are drawn as small tubular structures oriented parallel to the slit. (See '787 patent Fig. 8.) A cord, connected at its proximal end to an actuation handle, is threaded through these gussets, holding the edges of the housing part together. When the handle is pulled, the cord is withdrawn from the gussets, allowing the stent to expand.

The '787 patent issued on February 1, 2000 from U.S. Patent Application No. 08/946,657 (“the '657 application”), a divisional application of U.S. Patent Application No. 08/146,137 (“the '137 application”), which included eight claims. 3 During prosecution of the '137 application, the patent examiner determined that the claims were drawn to two separate inventions, “an expansible endoprosthesis” (claims 1-5) and “a tool for fitting an expansible endoprosthesis” (claims 6-8), and issued a restriction requirement, which required the applicants to elect one of these inventions for further examination. 4 (See Gallagher Opening Decl. Ex. B at 354-57.) The applicants elected the “endoprosthe-sis” claims and the examiner withdrew the “tool” claims from the application. (See Gallagher Opening Decl. Ex. B at 354-57.) The applicants refiled the “tool” claims on October 7, 1997 as the '657 application. (See Gallagher Opening Decl. Ex. B at 2-20.)

DISCUSSION

I. Perouse’s Motion to Exclude

In its Motion to Exclude, Perouse contends that the Court should refuse to consider several of the proposed claim constructions in Gore’s reply brief because these constructions are either worded differently from the corresponding constructions proposed in Gore’s opening brief or are constructions of claim terms that Gore did not construe at all in its opening brief. 5 (Perouse Mot. to Exclude Br. 4-5.)

Perouse complains that it is prejudiced by Gore’s “newly proposed” constructions *369 because Perouse has been denied the opportunity to respond. (Perouse Mot. to Exclude Br. 2, 10.) Furthermore, because Gore has proposed two different constructions for certain claim terms, Perouse alleges it was forced to “chas[e] a moving target” as it prepared for expert depositions and the Markman hearing. (Per-ouse Mot. to Exclude Br. 2.) Finally, Per-ouse alleges that Gore’s conduct forced Perouse to waste time and money preparing its Motion to Exclude. (Perouse Mot. to Exclude Br. 2.) 6 However, Perouse did not request leave to file a supplemental response to Gore’s reply brief, nor did Perouse request postponement of the Markman hearing.

The Court finds that, with respect to most of the constructions challenged by Perouse, there is no meaningful difference in scope between Gore’s original and “newly proposed” constructions. With respect to these constructions, the Court believes Perouse has suffered no prejudice because it had a full opportunity to respond to the substance of each “newly proposed” construction, if not the precise language. In other cases, these new constructions conform to Perouse’s proposed constructions, thereby eliminating unnecessary disputes. (Gore Opp. to Mot. to Exclude Br. 8, Ex. I.) In a few cases, however, Gore’s “newly proposed” constructions are in fact new, or include “clarifications” that assert arguments not made in Gore’s opening brief and to which Perouse therefore did not have an opportunity to respond in writing. The Court has not relied upon any of Gore’s constructions from this last category, and therefore need not consider whether Perouse has been prejudiced by Gore’s late advancement of its constructions and arguments.

II. Claim Construction

A. Legal Standard

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wyeth, LLC v. Intervet, Inc.
771 F. Supp. 2d 334 (D. Delaware, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
528 F. Supp. 2d 362, 2007 U.S. Dist. LEXIS 90848, 2007 WL 4323000, Counsel Stack Legal Research, https://law.counselstack.com/opinion/laboratoires-perouse-v-wl-gore-associates-inc-nysd-2007.